Dysregulation of tRNA methylation in cancer: Mechanisms and targeting therapeutic strategies
Wenbin Yuan, Rui Zhang, Hao Lyu, Shuai Xiao, Dong Guo, Qi Zhang, Declan W. Ali, Marek Michalak, Xing‐Zhen Chen, Cefan Zhou, Jingfeng Tang
Abstract
tRNA is the RNA type that undergoes the most modifications among known RNA, and in recent years, tRNA methylation has emerged as a crucial process in regulating gene translation. Dysregulation of tRNA abundance occurs in cancer cells, along with increased expression and activity of tRNA methyltransferases to raise the level of tRNA modification and stability. This leads to hijacking of translation and synthesis of multiple proteins associated with tumor proliferation, metastasis, invasion, autophagy, chemotherapy resistance, and metabolic reprogramming. In this review, we provide an overview of current research on tRNA methylation in cancer to clarify its involvement in human malignancies and establish a theoretical framework for future therapeutic interventions targeting tRNA methylation processes.